Esma Karadeniz-Gungormez, Department of Pediatric Surgery, Basaksehir Çam and Sakura City Hospital, Istanbul, Turkey
İbrahim Baytar, Department of Pediatric Surgery, Basaksehir Çam and Sakura City Hospital, Istanbul, Turkey
Betul B. Ozbal, Department of Pediatric Surgery, Basaksehir Çam and Sakura City Hospital, Istanbul, Turkey
Namik E. Akcan, Department of Pediatric Surgery, Bursa City Hospital, Bursa, Turkey
Mustafa Azizoglu, Deparment of Pediatric Surgery, Esenyurt Necmi Kadioglu State Hospital; Department of Stem Cell and Tissue Enginering, Health Sciences Institute, Istinye University. Istanbul, Turkey
Congenital diaphragmatic hernia (CDH) is a rare and complex developmental disorder characterized by diaphragmatic defects, pulmonary hypoplasia, and persistent pulmonary hypertension, leading to significant neonatal morbidity and mortality. This review summarizes current knowledge on the pathogenesis, genetic background, clinical features, and risk stratification of CDH. The etiology is multifactorial, involving genetic mutations, chromosomal abnormalities, and environmental influences, with key molecular pathways including the retinoic acid and Sonic Hedgehog signaling pathways. Advances in pre-natal diagnosis, particularly the ultrasound-based lung-to-head ratio and magnetic resonance imaging-derived total fetal lung volume, have improved prognostic assessment. Post-natal risk stratification using clinical parameters and scoring systems further guides management and predicts outcomes. Despite improvements in neonatal intensive care and surgical techniques, long-term morbidity remains a major concern. A comprehensive understanding of CDH pathophysiology and the integration of pre-natal and post-natal risk assessment are essential for optimizing individualized management strategies and improving survival and long-term outcomes.
Keywords: Congenital diaphragmatic hernia. Pulmonary hypoplasia. Pulmonary hypertension. Pathogenesis. Risk stratification.
